ICAP
  • Date: March 4-7, 2019
  • Location: Washington State Convention Center, Seattle, Washington

 

Click for conference program

 

In this video, Elaine J. Abrams, MD, professor of epidemiology and pediatrics at Columbia University, and clinical vice chair for the Conference on Retroviruses and Opportunistic Infections program committee, provides some insight into the many presentations occurring throughout the week. “This has already been a sensational meeting,” she says.

 

ICAP at CROI 2019

Monday, March 4
5:00 p.m. – 7:00 p.m.
Auditorium – 4AB

OS-1 OPENING SESSION

Session Hosts:

  • Richard A. Koup
    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
  • Sharon L. Hillier
    University of Pittsburgh, Pittsburgh, PA, USA
  • Elaine J. Abrams
    ICAP at Columbia University, New York, NY, USA

 

ICAP Oral and Poster Presentations


Tuesday, March 5
1:30 p.m. – 2:30 p.m.
Room 6C

Themed Discussion TD-03:
Let’s check in! New tools for monitoring ART and PrEP Adherence

  • Plasma EFV and TFV vs dried blood spot TFV-DP to predict viral suppression in women
    Presented by: Tamsin K. Phillips (also presented as a poster)

 

Tuesday, March 5
2:30 p.m. – 4:00 p.m.
Poster Hall – 4EF

  • Poster P-G1 (Objective assessment of adherence for PrEP and ART)
    Plasma EFV and TFV vs dried blood spot TFV-DP to predict viral suppression in women (#462)

    Presented by: Tamsin K. Phillips (also presented as a themed discussion)
  • Poster P-Q5 (Comorbidities and complications in children and youth with HIV)
    Growth and metabolic changes after antiretroviral start in South African children (#815)
    Presented by: Jennifer Jao
  • Poster P-T2 (Risk compensation, PrEP, and non-PrEP prevention)
    Voluntary medical male circumcision in Swaziland: achievements and gaps (#951)
    Presented by: Zandile Mnisi

 

Wednesday, March 6
10:00 a.m. – 12:00 p.m.
Room 6AB

Oral Abstract O-07:
TB: from contact to cure and beyond

  • Improving child tuberculosis contact management in Lesotho (#79; 10:30 a.m.)
    Presented by: Yael Hirsch-Moverman

 

Thursday, March 7
2:30 p.m. – 4:00 p.m.
Poster Hall – 4EF

  • Poster P-P4 (Maternal viral suppression and treatment outcomes)
    Long-term outcomes of an integrated maternal and child HIV care trial in South Africa (#763)
    Presented by: Tamsin K. Phillips
  • Poster P-T8 (PrEP adherence and persistence)
    Short-term retention on pre-exposure prophlyaxis in Democratic Republic of Congo (#996)
    Presented by: William Reidy

 

Related Items